Arantza Zornoza

Dr. Arantza Zornoza


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1999 in Cement and Concrete Research
Verified
Journal Article
Closed access
José Ignacio AlvarezJosé Ignacio Alvarez
José Ignacio Alvarez
AMA. Martı́n
A. Martı́n
PCP.J. Garcı́a Casado
P.J. Garcı́a Casado
INIñigo Navarro-Blasco
Iñigo Navarro-Blasco
AZArantza Zornoza
Arantza Zornoza

20 February 2017 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
Gustavo González-GaitanoGustavo González-Gaitano
Gustavo González-Gaitano
JIJosé Ramón Isasi
José Ramón Isasi
Itziar VélazItziar Vélaz
Itziar Vélaz
AZArantza Zornoza
Arantza Zornoza
The pharmaceutical applications of cyclodextrins (CDs), cyclic oligosaccharides capable of including hydrophobic molecules inside their cavities, have been known for decades. Besides the solubilising and encapsulating abilities of natural and modified CDs due to the formation of inclusion complexes, there is an increasing interest in organized macrostructures based on CDs as potential drug delivery devices and gene carrier systems. The present review discusses first the case of drug carriers based on monomeric modified CDs (amphiphilic and CD core-star polymers), in which self-assembly plays a major role. Polyrotaxanes, i.e., CDs threaded onto a polymer chain, are then reviewed in relation to their pharmaceutical applications. Finally, covalently linked CDs, either by grafting or crosslinking, are analyzed, including more complex structures formed by assembling CDcontaining networks or chains. We have tried along this review to cover the most recent developments on these structures for drug delivery in a “beyond the cyclodextrin” approach. The review will be helpful, both for readers who want to be introduced into the world of these remarkable structures, or for specialists who are doing research in this field.

1 January 2014 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
Eneko LarrañetaEneko Larrañeta
Eneko Larrañeta
CMCristina Martínez-Ohárriz
Cristina Martínez-Ohárriz
Itziar VélazItziar Vélaz
Itziar Vélaz
AZArantza Zornoza
Arantza Zornoza
RMRubén Machín
Rubén Machín
JIJosé Ramón Isasi
José Ramón Isasi

15 July 1998 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AZArantza Zornoza
Arantza Zornoza
Itziar VélazItziar Vélaz
Itziar Vélaz

1 January 2008 in Carbohydrate Polymers
Verified
Journal Article
Closed access
CGCarmen Gazpio
Carmen Gazpio
MSMiguel Sánchez
Miguel Sánchez
JIJosé Ramón Isasi
José Ramón Isasi
Itziar VélazItziar Vélaz
Itziar Vélaz
CMCarmen Martín
Carmen Martín
AZArantza Zornoza
Arantza Zornoza

1 March 2005 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
CGCarmen Gazpio
Carmen Gazpio
MSMiguel Sánchez
Miguel Sánchez
IGIñigo X. García-Zubiri
Iñigo X. García-Zubiri
Itziar VélazItziar Vélaz
Itziar Vélaz
CMCristina Martínez-Ohárriz
Cristina Martínez-Ohárriz
AZArantza Zornoza
Arantza Zornoza